The anti-HIV potential of imidazole,oxazole and thiazole hybrids: A mini-review |
| |
Institution: | 1. Hubei Engineering Research Center for Fragrant Plants, Hubei University of Science and Technology, Xianning, Hubei 437100, PR China;2. Xianning Research Academy of Industrial Technology of Osmanthus fragrans, Xianning, Hubei 437100, PR China;3. Hubei Provincial Institute for Food Supervision and Test, Wuhan, Hubei 430070, PR China |
| |
Abstract: | Human immunodeficiency virus (HIV) especially HIV-1 infection and its progression to acquired immune deficiency syndrome (AIDS) remains a significant global health challenge. The advent of the highly active antiretroviral therapy (HAART) has greatly extended the life expectancy of patients living with HIV, but it has become evident that long-term HAART will not eliminate the HIV reservoir and cure the infection. Moreover, the drug resistance and undesirable side effects hamper efficacious therapy, creating an urgent need to develop novel, more effective and less toxic anti-HIV therapeutics. Imidazole, oxazole and thiazole with two heteroatoms at meta-position of five-membered rings are fascinating structures and constitute an important class of heterocycles in drug discovery. Their derivatives could exert the anti-HIV activity through diverse mechanisms and possess promising antiviral activity against both drug-sensitive and drug-resistant HIV strains. This review summarizes the research progress made regarding the anti-HIV potential of imidazole, oxazole and thiazole hybrids, and the structure–activity relationships (SARs) are also discussed to facilitate further rational design of more effective candidates, covering articles published from 2012 to 2022. |
| |
Keywords: | Acquired immune deficiency syndrome Human immunodeficiency virus Imidazole Oxazole Thiazole Hybrid molecules |
本文献已被 ScienceDirect 等数据库收录! |
|